![Per Wold-Olsen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Per Wold-Olsen
Vorsitzender bei
ONCOPEPTIDES AB
Vermögen: 927 883 $ am 31.05.2026
Profil
Per Wold-Olsen ist ein norwegischer Geschäftsmann, der bereits 8 verschiedene Unternehmen geleitet hat. Derzeit ist er Vorsitzender bei GN Store Nord A, Vorsitzender von GN Audio A, Vorsitzender für GN Hearing An und Vorsitzender für GN Netcom A (die alle Tochtergesellschaften von GN Store Nord A sind) und Vorsitzender von Oncopeptides AB. Er ist außerdem im Aufsichtsrat von Gilead Sciences, Inc. und Bio Malter und Vorsitzender von MMV Medicines for Malaria Venture. Zuvor war er President-Intercontinental Division bei Merck & Co., Inc. und Chief Executive Officer bei MSD (Norge) AS (einer Tochtergesellschaft von Merck & Co., Inc.), Regional Director & Vice President bei MSD Scandinavia AS und Aufsichtsratsvorsitzender bei H. Lundbeck A. Er erhielt einen MBA von der University of Wisconsin und einen MBA von der BI Norwegian Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SENZIME AB 0.72% | 23.09.2025 | 1’126’344 ( 0.72% ) | 605 061 $ | 31.05.2026 |
ONCOPEPTIDES AB 0.42% | 09.06.2026 | 1’646’802 ( 0.42% ) | 322 823 $ | 31.05.2026 |
Aktuelle Nachrichten zu Per Wold-Olsen
Aktive Positionen von Per Wold-Olsen
| Unternehmen | Position | Beginn |
|---|---|---|
| ONCOPEPTIDES AB | Vorsitzender | 17.05.2018 |
| SENZIME AB | Vorsitzender | 01.11.2023 |
Bio Malter | Direktor/Vorstandsmitglied | - |
Forepont Capital LLC
 Forepont Capital LLC Investment ManagersFinance Forepont Capital Partners invests in companies located in United States, western Europe, Singapore, Australia, and Israel. The firm focuses on sectors such as biotech, medtech, and e-health. It participates in early-stage transactions. | Direktor/Vorstandsmitglied | - |
GN Hearing A/S
 GN Hearing A/S Medical SpecialtiesHealth Technology Manufactures hearing-aid devices | Vorsitzender | 16.06.2008 |
MMV Medicines for Malaria Venture
 MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services Develops antimalarial drugs | Vorsitzender | - |
Ehemalige bekannte Positionen von Per Wold-Olsen
| Unternehmen | Position | Ende |
|---|---|---|
| GN STORE NORD A/S | Vorsitzender | 15.03.2023 |
| AMARIN CORPORATION PLC | Vorsitzender | 28.02.2023 |
| H. LUNDBECK A/S | Vorsitzender | 30.03.2011 |
| ░░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Per Wold-Olsen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
98
Beziehungen ersten Grades
23
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 23 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Amarin Corp. Plc
 Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
Royal Numico NV
 Royal Numico NV Food: Specialty/CandyConsumer Non-Durables Manufactures baby food and clinical nutrition products | Consumer Non-Durables |
inVentiv Health Clinical, Inc.
 inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research and drug development services | Commercial Services |
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Glyconix Corp.
 Glyconix Corp. Pharmaceuticals: MajorHealth Technology Manufactures anti infective and oncology drugs | Health Technology |
Senzime AB
 Senzime AB Medical SpecialtiesHealth Technology Develops and markets an enzyme based biosensor technology | Health Technology |
GN Store Nord A/S
 GN Store Nord A/S Telecommunications EquipmentElectronic Technology Provides telecommunications and hearing instruments | Electronic Technology |
GN Audio A/S
 GN Audio A/S Electronic Production EquipmentElectronic Technology Develops, manufactures, and markets corded and wireless headsets, amplifiers for headsets, and headset telephones | Electronic Technology |
GN Hearing A/S
GN Hearing A/S Medical SpecialtiesHealth Technology Manufactures hearing-aid devices | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
 Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Exiqon A/S
 Exiqon A/S Miscellaneous Commercial ServicesCommercial Services Engages in the pharmaceutical industry | Commercial Services |
BI Norwegian Business School
 BI Norwegian Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
World Growth | |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services Develops antimalarial drugs | Commercial Services |
PharmaSet SAS
 PharmaSet SAS Medical SpecialtiesHealth Technology Manufactures and distributes disposable healthcare kits for hospital use | Health Technology |
MSD (Norge) AS
 MSD (Norge) AS Pharmaceuticals: MajorHealth Technology Engages in researching, manufacturing and marketing of drugs | Health Technology |
Bio Malter | |
MSD Scandinavia AS | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings-IC aims to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. The firm invests in almost all life science segments including pharmaceuticals, biotechnology, medical technology, healthcare services and industrial BioSolutions. Outside of the life sciences they invest in a diversified portfolio of equities, fixed income, real assets and alternatives. | Finance |
Forepont Capital LLC
Forepont Capital LLC Investment ManagersFinance Forepont Capital Partners invests in companies located in United States, western Europe, Singapore, Australia, and Israel. The firm focuses on sectors such as biotech, medtech, and e-health. It participates in early-stage transactions. | Finance |
